/var/www/dirigible/wp-content/themes/dirigible/functions/dirigible/helpers.php on line 125
https://www.ophth.wisc.edu/wp-content/uploads/2017/03/DS_DOVS-9-1-1600x1000.jpg" /> Cat Burkat, MD, FACS, Named ASOPRS Program Chair  – UW DOVS

Cat Burkat, MD, FACS, Named ASOPRS Program Chair 

Cat Burkat // Oculofacial // Jul 23 2019

Cat Burkat


Dr. Cat Burkat, professor and oculoplastics specialist, was recently elected to the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Program Chair role starting in 2020. Once approved by the full membership in fall 2019, she will serve as the assistant chair at the ASOPRS fall meeting in 2020, program chair of the spring meeting in 2021, and overall program chair of the fall meeting in 2022.

The American Society of Ophthalmic Plastic and Reconstructive Surgery is dedicated to the health and beauty of the eyes and face. Founded in 1969, ASOPRS now has over 650 US and 100 international members in over 30 countries around the world dedicated to facial rejuvenation and disorders of the eyelids, eye socket and tear drainage system. The Society publishes the scientific journal, Ophthalmic Plastic and Reconstructive Surgeryhosts an annual members-only spring conference and every autumn, sponsors the largest international meeting dedicated to oculofacial plastic surgery in the world.

ASOPRS accredits and oversees over 60 fellowship training programs throughout the country and administers the written and oral board examinations that are given upon completion of these highly competitive, 2-year training programs. Physician eye doctors must have completed extensive clinical and surgical training, published scholarly research and passed rigorous written and oral examinations in order to become members of ASOPRS.

The Society enjoys a strong tradition of volunteerism with 100+ members engaged in over 35 committees on education, patient safety, regulatory affairs, and practice management. ASOPRS is proud to mark its Golden Jubilee in 2019, celebrating 50 years of excellence and leadership in the field of oculofacial plastic and reconstructive surgery.